DE FRANCESCO, ERNESTINA MARIANNA
 Distribuzione geografica
Continente #
EU - Europa 567
AS - Asia 522
NA - Nord America 472
SA - Sud America 188
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.765
Nazione #
US - Stati Uniti d'America 453
IE - Irlanda 398
HK - Hong Kong 230
SG - Singapore 230
BR - Brasile 170
IT - Italia 41
DE - Germania 38
GB - Regno Unito 24
FI - Finlandia 16
TR - Turchia 15
FR - Francia 12
CA - Canada 9
BD - Bangladesh 8
IN - India 8
BE - Belgio 7
LT - Lituania 7
JP - Giappone 6
VE - Venezuela 6
VN - Vietnam 6
AR - Argentina 5
MA - Marocco 5
MX - Messico 5
ZA - Sudafrica 5
IQ - Iraq 4
JM - Giamaica 4
NL - Olanda 4
CH - Svizzera 3
EG - Egitto 3
ES - Italia 3
SE - Svezia 3
HR - Croazia 2
KG - Kirghizistan 2
KR - Corea 2
NP - Nepal 2
PL - Polonia 2
PY - Paraguay 2
SN - Senegal 2
UA - Ucraina 2
UZ - Uzbekistan 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
LV - Lettonia 1
MK - Macedonia 1
MV - Maldive 1
PE - Perù 1
PK - Pakistan 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.765
Città #
Dublin 388
Hong Kong 230
Boardman 86
Santa Clara 73
Singapore 69
The Dalles 64
Dallas 53
Los Angeles 37
Munich 22
São Paulo 20
Assago 16
Istanbul 14
Helsinki 12
Chicago 10
Belo Horizonte 9
Frankfurt am Main 9
Ashburn 8
Rio de Janeiro 8
Brussels 7
Columbus 7
Lauterbourg 7
London 7
Milan 5
Naples 5
Düsseldorf 4
Tokyo 4
Turku 4
Atlanta 3
Brooklyn 3
Florence 3
Ho Chi Minh City 3
Johannesburg 3
Kingston 3
New York 3
Ottawa 3
Phoenix 3
Porto Alegre 3
Pune 3
San Francisco 3
Toronto 3
Zurich 3
Amsterdam 2
Anoia Superiore 2
Bishkek 2
Brasília 2
Camden 2
Campinas 2
Caracas 2
Cardiff 2
Casablanca 2
Caxias do Sul 2
Dakar 2
Dhaka 2
Fortaleza 2
Grammichele 2
Guarulhos 2
Indianapolis 2
Kurosunadai 2
Maracanaú 2
Nova Friburgo 2
Olímpia 2
Paris 2
Partanna 2
Pelotas 2
Portsmouth 2
Punto Fijo 2
Rabat 2
Raleigh 2
Recife 2
Rome 2
Salvador 2
Secaucus 2
Seoul 2
Stockholm 2
São Bernardo do Campo 2
São Vicente 2
Tashkent 2
Warsaw 2
West Jordan 2
Zagreb 2
Acapulco de Juárez 1
Agadir 1
Al Mansurah 1
Alto Rio Doce 1
Alvin 1
Alvorada d'Oeste 1
Amman 1
Amparo 1
Amstelveen 1
Araras 1
Arribeños 1
Augusta 1
Barnet 1
Battle Creek 1
Betim 1
Bharatpur 1
Bom Jardim 1
Bom Jesus dos Perdões 1
Botumirim 1
Buenos Aires 1
Totale 1.318
Nome #
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 59
Cross-talk between GPER and growth factor signaling 54
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 45
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 44
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: Mechanisms and models 42
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 37
The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1α (HIF-1α) in breast cancer cells and cardiomyocytes 37
Editorial: A year in review: discussions in molecular and structural endocrinology 37
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 37
G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts 37
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 37
COVID-19 and Diabetes: The Importance of Controlling RAGE 36
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 35
Cancer stem cells (CSCs): Metabolic strategies for their identification and eradication 35
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 34
NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness" 34
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 34
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 33
The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells 33
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 32
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 32
Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts 32
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 32
The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes 31
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 31
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 31
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 31
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 30
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 30
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 30
Editorial: Early diagnoses and treatments of uncommon breast cancers 30
Crosstalk between notch, HIF-1α and GPER in breast cancer EMT 29
Estrogen Receptors and Chronic Venous Disease 29
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 29
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 28
Crucial role of phospholamban phosphorylation and s-nitrosylation in the negative lusitropism induced by 17β-estradiol in the male rat heart 28
Protective role of GPER Agonist G-1 on cardiotoxicity induced by doxorubicin 27
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine) 27
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 25
Multifactorial regulation of GPER expression in cancer cells and cardiomyocytes 25
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells 25
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 24
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 24
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells 23
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 23
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 23
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 22
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 22
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy 21
Two novel GPER agonists induce gene expression changes and growth effects in cancer cells 21
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 20
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 20
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 20
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 20
Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts 19
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 19
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 18
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 18
GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment 18
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 17
GPER mediates activation of HIF1α/VEGF signaling by estrogens 17
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 16
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs) 16
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 16
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC) 14
Pregnancy augments G protein estrogen receptor (GPER) induced vasodilation in rat uterine arteries via the nitric oxide - cGMP signaling pathway 14
GPER mediates cardiotropic effects in Spontaneously Hypertensive Rat hearts 13
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience 12
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 10
Totale 1.904
Categoria #
all - tutte 14.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 1 0 1 0 1 0 0
2022/20233 2 0 0 0 0 0 0 0 0 0 1 0
2023/2024441 0 1 1 0 1 1 2 63 75 76 156 65
2024/20251.292 85 72 92 35 183 103 84 58 205 170 127 78
2025/2026165 165 0 0 0 0 0 0 0 0 0 0 0
Totale 1.904